Meet Dr Jonas Frisen, one of the most successful scientists within stem cell research, at an R&D session in the worlds largest convention for biotech and pharmaceuticals, BIO 2009 in Atlanta, USA. The session is arranged by the Swedish medical university Karolinska Institutet, SwedenBIO and Invest in Sweden Agency.
Dr. Frisn will talk about stem cell research, currently one of the most exciting areas in science, and how it unravels potential new therapies for Parkinson's, Alzheimer's, spinal cord injury, stroke, heart diseases and other devastating diseases.
He is also the scientific founder of NeuroNova, a biopharmaceutical company, developing stem cell-based therapies for neurological disorders in the central nervous system. NeuroNova has two drug candidates in clinical development, one for Parkinson's disease and one for ALS.
The session will be chaired by Ceci Connolly, National Healthcare Reporter at Washington Post.
R&D session at BIO 2009 - Breaking new stem cell research unlocks unknown therapies
Time: Thursday 21 May at 10:00 am.
Location: Georgia World Congress Center, Room B308, Atlanta.
Key Speaker: Jonas frisn, M.D., Ph.D., Tobias Foundation Professor of Stem Cell Research, Karolinska Institutet, Sweden.
Speaker: Lilian Wikstrm, Ph.D., Head of Research, NeuroNova AB.
Chair: Ceci Connolly, National Healthcare Reporter, Washington Post.
|Contact: Sabina Bossi|